What this study is
This study will test a tailored, multilingual tobacco cessation chatbot called LIFT-UP (LLM Intervention for Tobacco in Underserved Populations), designed to better meet the needs of people living in persistent poverty census tracts.
This study will use 1:1 semi-structured interviews to explore social drivers of health impacting TC, as well as digital access and preferences among those living in PPCTs. This qualitative approach enables guided yet flexible exploration of key domains while capturing unanticipated insights relevant to refining the chatbot.
What's being tested
- LIFT-UP Chatbot
Intervention · BEHAVIORAL
LIFT-UP Chatbot will be developed, evaluated, and refined using GARDE-Chat, an open-source chatbot authoring platform that has been used to support the development of chatbot-based interventions tested in large pragmatic clinical trials.
Study details
- Sponsor
- University of Utah
- Conditions
- Smoking Cessation
- Enrolling
- 22 people
- Starts
- 2026-11-01
- Est. completion
- 2027-05-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- 18+ years old
- Use ≥3 cigarettes/day on average
- Motivated to quit in the next 30 days
- Have a computer or tablet with internet access for 1:1 interviews
- Speak English or Spanish
- Home address is in an area characterized by persistent poverty
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openHuntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, United States
- Lindsey Potter, MPH, PhD · Contact801-213-6036lindsey.potter@hci.utah.edu
- Lindsey Potter, MPH, PhD · Principal investigator
- Christian Mahony Reategui Rivera, MD, MS · Principal investigator
Study team
Sponsor
University of Utah
Study ID 199440
Principal investigator
Chelsey Schlechter, MPH, PhD
Huntsman Cancer Institute
Principal investigator
Christian Mahony Reategui Rivera, MD, MS
University of Utah
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.